147
Participants
Start Date
July 28, 2020
Primary Completion Date
October 6, 2021
Study Completion Date
October 15, 2021
BI 1015550
18 milligram (mg) BI 1015550 taken orally as film-coated tablets (1x 6mg tablet, 1x 12 mg tablet) twice daily (36 mg daily), in the morning and in the evening for 12 weeks.
Placebo
placebo matching BI 1015550 taken orally as film-coated tablets (matching the respective BI 1015550 tablets) twice daily, in the morning and in the evening for 12 weeks.
Semmelweis University, Budapest
Herlev and Gentofte Hospital, Hellerup
The Alfred Hospital, Melbourne
Odense University Hospital, Odense C
LKH-Univ. Hospital Graz, Graz
Aarhus University Hospital, Aarhus N
The Catholic University of Korea, Bucheon St.Mary's Hospital, Bucheon-si
Athens Medical Center, Athens
Temple University Hospital, Philadelphia
TYKS, Turku
Univ. Gen. Hosp. of Patras, Pátrai
Southeastern Research Center, Winston-Salem
Hospital La Princesa, Madrid
University of Florida, Gainesville
Hospital Central de Asturias, Oviedo
Tampere University Hospital, Tampere
St. Francis Medical Institute, Clearwater
Lungenfachklinik Immenhausen, Immenhausen
Azienda Ospedaliera Universitaria di Padova, Padua
The Ohio State University Wexner Medical Center, Columbus
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, Essen
Universitätsklinikum Münster, Münster
Dnyepropyetrovsk Medical Academy, Clinical Hospital No. 6, Dnyepropyetrovsk
A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena
Mayo Clinic, Rochester, Rochester
The Lung Research Center, LLC, Chesterfield
University of Kansas Medical Center, Kansas City
Creighton University, Omaha
Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg
KYS, Keuhkosairauksien, Kuopio
Ospedale Colonnello D Avanzo, Foggia
University General Hospital of Heraklion, Crete
Diagnostics Research Group, San Antonio
University of Utah Health Sciences Center, Salt Lake City
Peking Union Medical College Hospital, Beijing
"Federal state budgetary scientific institution Research Institute of occupational medicine named after academician N. F. Izmerov", Moscow
Moscow 1st State Med.Univ.n.a.I.M.Sechenov, Moscow
The Second Hospital of Jilin University, Changchun
Emergency Clinical Hospital n. a. N. V. Solovyev, Yaroslavl, Yaroslavl
Zhongshan Hospital Fudan University, Shanghai
Shanghai Pulmonary Hospital, Shanghai
West China Hospital, Chengdu
Centro de Investigación del Maule, Talca
Instituto Nacional del Tórax, Providencia, Santiago de Chile
Centro de Investigaciones Metabólicas (CINME), C.a.b.a
St. Paul's Hospital, Vancouver
Dr. Georges-L.-Dumont University Hospital Centre, Moncton
Queen's University, Kingston
Dr. Syed Anees Medicine Professional Corporation, Windsor
Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal
University Hospital Na Bulovce, Prague, Prague
University Thomayer's Hospital, Praha 4 - Krc
HYKS Keuhkosairauksien tutkimusyksikkö, Helsinki
Oulun yliopistollinen keskussairaala, Oulu
Fachkrankenhaus Coswig GmbH, Coswig
Poli Univ A. Gemelli, Roma
Tosei General Hospital, Aichi, Seto
National Hospital Organization Kyushu Medical Center, Fukuoka, Fukuoka
Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Yokohama
National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Sakai
Hamamatsu University Hospital, Shizuoka, Hamamatsu
Center Hospital of the National Center for Global Health and Medicine, Tokyo, Shinjuku-ku
Zuyderland Medisch Centrum, Heerlen
St. Antonius ziekenhuis, locatie Nieuwegein, Nieuwegein
Erasmus Medisch Centrum, Rotterdam
University Clinical Center, Gdansk, Gdansk
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Policlínica Barcelona, Barcelona
Hospital Clínic de Barcelona, Barcelona
Hospital de Bellvitge, L'Hospitalet de Llobregat
Hospital Son Espases, Palma de Mallorca
Instit.Phthisiology&Pulmon.na Yanovskiy,Non-Specif.Lung,Kyiv, Kyiv
Southmead Hospital, Bristol
Royal Brompton Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY